165 related articles for article (PubMed ID: 35752779)
1. Isolated central nervous system relapses in patients with high-risk neuroblastoma -clinical presentation and prognosis: experience of the Polish Paediatric Solid Tumours Study Group.
Wieczorek A; Stefanowicz J; Hennig M; Adamkiewicz-Drozynska E; Stypinska M; Dembowska-Baginska B; Gamrot Z; Woszczyk M; Geisler J; Szczepanski T; Skoczen S; Ussowicz M; Pogorzala M; Janczar S; Balwierz W
BMC Cancer; 2022 Jun; 22(1):701. PubMed ID: 35752779
[TBL] [Abstract][Full Text] [Related]
2. Central nervous system relapse in high-risk stage 4 neuroblastoma: The HR-NBL1/SIOPEN trial experience.
Berlanga P; Pasqualini C; Pötschger U; Sangüesa C; Castellani MR; Cañete A; Luksch R; Elliot M; Schreier G; Kropf M; Morgenstern D; Papadakis V; Ash S; Ruud E; Brock P; Wieczorek A; Kogner P; Trahair T; Ambros P; Boterberg T; Castel V; Valteau-Couanet D; Ladenstein R
Eur J Cancer; 2021 Feb; 144():1-8. PubMed ID: 33316634
[TBL] [Abstract][Full Text] [Related]
3. [Central nervous system involvement at diagnosis and at relapse in children with neuroblastoma].
Wieczorek A; Balwierz W; Wyrobek Ł; Garus K; Kwiatkowski S; Kwiecińska K; Walicka-Soja K
Przegl Lek; 2010; 67(6):399-403. PubMed ID: 21344769
[TBL] [Abstract][Full Text] [Related]
4. [Central nervous system metastases in children with solid tumours].
Nurzyńska-Flak J; Zawitkowska-Klaczyńska J; Katski K; Kowalczyk JR
Med Wieku Rozwoj; 2004; 8(2 Pt 1):175-82. PubMed ID: 15738591
[TBL] [Abstract][Full Text] [Related]
5. [Occurrence and prognostic impact of selected factors in neuroblastoma in children].
Wieczorek A; Balwierz W
Przegl Lek; 2010; 67(6):393-8. PubMed ID: 21344768
[TBL] [Abstract][Full Text] [Related]
6. [Tumours in newborns and infants up to three months of life. One institution experience].
Perek D; Brozyna A; Dembowska-Baginska B; Stypinska M; Sojka M; Bacewicz L; Polnik D; Kalicinski P
Med Wieku Rozwoj; 2006; 10(3 Pt 1):711-23. PubMed ID: 17317902
[TBL] [Abstract][Full Text] [Related]
7. Temporal changes in the incidence and pattern of central nervous system relapses in children with acute lymphoblastic leukaemia treated on four consecutive Medical Research Council trials, 1985-2001.
Krishnan S; Wade R; Moorman AV; Mitchell C; Kinsey SE; Eden TO; Parker C; Vora A; Richards S; Saha V
Leukemia; 2010 Feb; 24(2):450-9. PubMed ID: 20016529
[TBL] [Abstract][Full Text] [Related]
8. Neuroblastoma metastatic to the central nervous system. The Memorial Sloan-kettering Cancer Center Experience and A Literature Review.
Kramer K; Kushner B; Heller G; Cheung NK
Cancer; 2001 Apr; 91(8):1510-9. PubMed ID: 11301399
[TBL] [Abstract][Full Text] [Related]
9. Central nervous system metastases in neuroblastoma: radiologic, clinical, and biologic features in 23 patients.
Matthay KK; Brisse H; Couanet D; Couturier J; Bénard J; Mosseri V; Edeline V; Lumbroso J; Valteau-Couanet D; Michon J
Cancer; 2003 Jul; 98(1):155-65. PubMed ID: 12833468
[TBL] [Abstract][Full Text] [Related]
10. Relapse patterns in pediatric embryonal central nervous system tumors.
Perreault S; Lober RM; Carret AS; Zhang G; Hershon L; Décarie JC; Yeom K; Vogel H; Fisher PG; Partap S
J Neurooncol; 2013 Nov; 115(2):209-15. PubMed ID: 23921420
[TBL] [Abstract][Full Text] [Related]
11. Isolated central nervous system recurrence in a child with stage IV neuroblastoma.
Sidi-Fragandrea V; Hatzipantelis E; Panagopoulou P; Fragandrea I; Anastasiou A; Koliouskas DE
Pediatr Hematol Oncol; 2010 Aug; 27(5):387-92. PubMed ID: 20469973
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcomes of pediatric patients receiving multimodality treatment of second central nervous system relapse of neuroblastoma.
Tringale KR; Wolden SL; Casey DL; Kushner BH; Luo L; Pandit-Taskar N; Souweidane M; Cheung NV; Modak S; Basu EM; Kramer K
Pediatr Blood Cancer; 2023 Feb; 70(2):e30075. PubMed ID: 36349892
[TBL] [Abstract][Full Text] [Related]
13. Factors associated with recurrence and survival length following relapse in patients with neuroblastoma.
Basta NO; Halliday GC; Makin G; Birch J; Feltbower R; Bown N; Elliott M; Moreno L; Barone G; Pearson AD; James PW; Tweddle DA; McNally RJ
Br J Cancer; 2016 Oct; 115(9):1048-1057. PubMed ID: 27701387
[TBL] [Abstract][Full Text] [Related]
14. Loss of chromosome 1p may have a prognostic value in localised neuroblastoma: results of the French NBL 90 Study. Neuroblastoma Study Group of the Société Française d'Oncologie Pédiatrique (SFOP).
Rubie H; Delattre O; Hartmann O; Combaret V; Michon J; Bénard J; Peyroulet MC; Plantaz D; Coze C; Chastagner P; Baranzelli MC; Frappaz D; Lemerle J; Sommelet D
Eur J Cancer; 1997 Oct; 33(12):1917-22. PubMed ID: 9516824
[TBL] [Abstract][Full Text] [Related]
15. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
16. The effect of central nervous system involvement and irradiation in childhood acute lymphoblastic leukemia: Lessons from the NOPHO ALL-92 and ALL-2000 protocols.
Taskinen M; Oskarsson T; Levinsen M; Bottai M; Hellebostad M; Jonsson OG; Lähteenmäki P; Schmiegelow K; Heyman M
Pediatr Blood Cancer; 2017 Feb; 64(2):242-249. PubMed ID: 27748030
[TBL] [Abstract][Full Text] [Related]
17. Neuroblastoma in adolescents: the Italian experience.
Conte M; Parodi S; De Bernardi B; Milanaccio C; Mazzocco K; Angelini P; Viscardi E; Di Cataldo A; Luksch R; Haupt R
Cancer; 2006 Mar; 106(6):1409-17. PubMed ID: 16475209
[TBL] [Abstract][Full Text] [Related]
18. Isolated central nervous system relapses in primary mediastinal large B-cell lymphoma after CHOP-like chemotherapy with or without Rituximab.
Papageorgiou SG; Diamantopoulos P; Levidou G; Angelopoulou MK; Economopoulou P; Efthimiou A; Constantinou N; Katsigiannis A; Korkolopoulou P; Pappa V; Economopoulou C; Georgiou G; Dimou M; Tsirigotis P; Kyrtsonis MC; Kotsianidis I; Kalpadakis C; Dimopoulos MA; Beris P; Meletis J; Pangalis GA; Dervenoulas J; Panayiotidis P; Vassilakopoulos TP
Hematol Oncol; 2013 Mar; 31(1):10-7. PubMed ID: 22610484
[TBL] [Abstract][Full Text] [Related]
19. Deep MicroRNA sequencing reveals downregulation of miR-29a in neuroblastoma central nervous system metastasis.
Cheung IY; Farazi TA; Ostrovnaya I; Xu H; Tran H; Mihailovic A; Tuschl T; Cheung NK
Genes Chromosomes Cancer; 2014 Oct; 53(10):803-14. PubMed ID: 24898736
[TBL] [Abstract][Full Text] [Related]
20. Targeted Analysis of Cell-free Circulating Tumor DNA is Suitable for Early Relapse and Actionable Target Detection in Patients with Neuroblastoma.
Lodrini M; Graef J; Thole-Kliesch TM; Astrahantseff K; Sprüssel A; Grimaldi M; Peitz C; Linke RB; Hollander JF; Lankes E; Künkele A; Oevermann L; Schwabe G; Fuchs J; Szymansky A; Schulte JH; Hundsdörfer P; Eckert C; Amthauer H; Eggert A; Deubzer HE
Clin Cancer Res; 2022 May; 28(9):1809-1820. PubMed ID: 35247920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
